Skip to nav Skip to content
Facebook Twitter LinkedIn Email




Court Decision Protects Patient Care 340B Hospitals

The Dec. 27 federal court injunction stopping further cuts in 340B reimbursements for Medicare Part B drugs to some participating hospitals is a critical step in preserving the role that academic health centers play in providing HIV, viral hepatitis, and other infectious disease treatment and prevention services to patients who otherwise lack care options.

The Infectious Diseases Society of America and HIV Medicine Association have opposed the 340B payment decreases proposed for 2019, and those that were imposed in 2018. In addition to supporting infectious diseases prevention and treatment services, safety-net hospitals use savings from the program to fund frontline services critical to confronting the opioid and HIV epidemics, including substance use treatment, transitional housing, and other support services.

We will continue to urge the restoration to affected hospitals of the cuts made in 2018. 

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.